Akorn (AKRX) Stock: Climbing On 2 FDA Approvals
Akorn, Inc. (NASDAQ: AKRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced multiple FDA approvals over the Good Friday/Easter holiday break. As you could imagine, the approvals led to excitement among investors who are pushing the stock on a run for the top. Today, … Read more